Baroda BNP Paribas Health & Wellness Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness Growth Direct Plan

NAV
₹9.1069
-2.01%
(23 Mar)
AUM
565 Cr
TER
0.6%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+18.1%
+17.3%
+15.5%
+10.7%
NA
3Y
+33.0%
+29.9%
+30.6%
+28.4%
NA
5Y
+27.5%
+27.0%
+25.7%
+24.1%
NA
ALL
+12.1%
+23.9%
+16.3%
+15.1%
-8.9%
VOL
20.0%
21.9%
19.7%
18.4%
11.0%
TER
0.8%
0.6%
0.9%
1.0%
0.6%
AUM
₹6,545 Cr
₹6,086 Cr
₹1,511 Cr
₹1,007 Cr
₹565 Cr
INFO
0.60
1.09
0.83
0.82
-0.82
See fund holdings as of 28th Feb
Top holdings
Sun Pharmaceuticals Industries Ltd
9.2%
Max Healthcare Institute Ltd Ordinary Shares
6.4%
Lupin Ltd
5.7%
Aster DM Healthcare Ltd Ordinary Shares
5.2%
Torrent Pharmaceuticals Ltd
5.0%
Abbott India Ltd
4.6%
Fortis Healthcare Ltd
4.6%
Apollo Hospitals Enterprise Ltd
4.2%
Laurus Labs Ltd
4.1%
AstraZeneca Pharma India Ltd
4.1%
Top industry exposure
Healthcare
87.5%
Financial Services
7.0%
Basic Materials
1.3%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
50%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs